4//SEC Filing
SAYARE MITCHEL 4
Accession 0001012975-18-000335
CIK 0001326190other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 8:27 PM ET
Size
5.4 KB
Accession
0001012975-18-000335
Insider Transaction Report
Form 4
SAYARE MITCHEL
Director
Transactions
- Award
Stock Options (option to buy)
2018-04-05+35,000→ 35,000 totalExercise: $0.95Exp: 2028-04-05→ Common Stock, par value $0.0001 (35,000 underlying)
Footnotes (1)
- [F1]Fifty percent of the option will become vested and exercisable on June 30, 2018 and the remaining 50% of the option will vest and become exercisable on December 31, 2018.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001201196
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 8:27 PM ET
- Size
- 5.4 KB